{
  "name": "Immunovia",
  "slug": "immunovia",
  "description": "Statiskt källarkiv med kurshistorik, finansiella rapporter och regulatoriska dokument. För nordiska bolag används Nasdaq Nordic primärt och MFN endast för saknade rapportperioder.",
  "status": "complete",
  "updated_at": "2026-08-07T04:13:08Z",
  "nasdaq_status": "retrieved",
  "latest_market": "2026-08-06: stängning 0.1756, volym 5403135",
  "mfn_status": "resolved_no_reports",
  "mfn_count": 0,
  "nasdaq_reports_status": "retrieved",
  "reports": {
    "available": true,
    "url": "/company/immunovia/reports",
    "count": 17,
    "nasdaq_count": 17,
    "mfn_fallback_count": 0,
    "items": [
      {
        "report_key": "2026:q2",
        "period_label": "2026 Q2",
        "date": "2026-08-06",
        "title": "Kvartalsrapport Q2 2026",
        "original_title": "Immunovia publicerar Delårsrapport april-juni 2026",
        "category": "Halvårsrapport",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=b2811f5df23ff37a6e07020eafddb689b&lang=sv&src=listed",
        "language": "sv",
        "report_type": "interim-report",
        "fiscal_year": 2026,
        "quarter": "q2",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q2-2026",
            "title": "Kvartalsrapport Q2 2026",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/ae1f417bd344855d4ceb5689dc8cbb99a",
            "date": "2026-08-06",
            "period": "2026-q2",
            "form_type": "interim-report",
            "report_key": "2026:q2",
            "filename": "Immunovia_Delarsrapport_Q2_2026.pdf",
            "text_chars": 54040,
            "sha256": "dd64257dad51d8e061ea554c48d6f4705c367b942e47569c3f24b02b0c4de2dc",
            "url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q2-2026",
            "absolute_url": "https://spela.port0.org/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q2-2026",
            "txt_url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q2-2026/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q2-2026/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q2-2026/part-001.html",
                "chars": 54040
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2026:q1",
        "period_label": "2026 Q1",
        "date": "2026-05-07",
        "title": "Kvartalsrapport Q1 2026",
        "original_title": "Rättelse: Immunovia publicerar Delårsrapport januari-mars 2026",
        "category": "Interimsrapport",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=b1a6666ce1414ec4a14c8c9fa1bf0d3fd&lang=sv&src=listed",
        "language": "sv",
        "report_type": "interim-report",
        "fiscal_year": 2026,
        "quarter": "q1",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2026",
            "title": "Kvartalsrapport Q1 2026",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/a9f26903c3283771aae8384f7671d2965",
            "date": "2026-05-07",
            "period": "2026-q1",
            "form_type": "interim-report",
            "report_key": "2026:q1",
            "filename": "Immunovia_Delarsrapport_Q1_2026.pdf",
            "text_chars": 51299,
            "sha256": "82e9edf4b17f2d80be0d79e78b699609f88a57293279f46a189ff73ed86cb4b4",
            "url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q1-2026",
            "absolute_url": "https://spela.port0.org/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q1-2026",
            "txt_url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q1-2026/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q1-2026/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q1-2026/part-001.html",
                "chars": 51299
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2025:annual",
        "period_label": "2025 Årsredovisning",
        "date": "2026-04-10",
        "title": "Årsredovisning 2025",
        "original_title": "Immunovia publicerar årsredovisningen för 2025",
        "category": "Bokslut och Verksamhetsberättelse",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=b4f471ae9e79c966a43e7d980eb4e12c3&lang=sv&src=listed",
        "language": "sv",
        "report_type": "annual-report",
        "fiscal_year": 2025,
        "quarter": "annual",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-arsredovisning-2025",
            "title": "Årsredovisning 2025",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/a003a0716b3c489d57e20b93cb41e4694",
            "date": "2026-04-10",
            "period": "2025-annual",
            "form_type": "annual-report",
            "report_key": "2025:annual",
            "filename": "Immunovia_AB_publ_Arsredovisning_2025.pdf",
            "text_chars": 180734,
            "sha256": "5835d188655b3c9f74e66c3ca06c35c44edf4fe2635245fa7978fbb34fd49ac5",
            "url": "/company/immunovia/documents/nasdaq-nordic-arsredovisning-2025",
            "absolute_url": "https://spela.port0.org/company/immunovia/documents/nasdaq-nordic-arsredovisning-2025",
            "txt_url": "/company/immunovia/documents/nasdaq-nordic-arsredovisning-2025/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/immunovia/documents/nasdaq-nordic-arsredovisning-2025/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/immunovia/documents/nasdaq-nordic-arsredovisning-2025/part-001.html",
                "chars": 179700
              },
              {
                "number": 2,
                "url": "/company/immunovia/documents/nasdaq-nordic-arsredovisning-2025/part-002.html",
                "chars": 1032
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2025:q4",
        "period_label": "2025 Q4",
        "date": "2026-02-24",
        "title": "Kvartalsrapport Q4 2025",
        "original_title": "Immunovia publicerar Bokslutskommuniké 2025",
        "category": "Bokslutskommuniké",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=b95025f0bd10ccc70b2fd8ceccd20986a&lang=sv&src=listed",
        "language": "sv",
        "report_type": "year-end-report",
        "fiscal_year": 2025,
        "quarter": "q4",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q4-2025",
            "title": "Kvartalsrapport Q4 2025",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/a9a34f3722386ab8c29d882a04d530924",
            "date": "2026-02-24",
            "period": "2025-q4",
            "form_type": "year-end-report",
            "report_key": "2025:q4",
            "filename": "Bokslutskommunike_2025.pdf",
            "text_chars": 52683,
            "sha256": "2c0698add5bcd649088d1f7d8281bcf564f857711ae658b11c6ef51fe29ac391",
            "url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q4-2025",
            "absolute_url": "https://spela.port0.org/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q4-2025",
            "txt_url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q4-2025/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q4-2025/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q4-2025/part-001.html",
                "chars": 52683
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2025:q3",
        "period_label": "2025 Q3",
        "date": "2025-11-26",
        "title": "Kvartalsrapport Q3 2025",
        "original_title": "Immunovia publicerar Delårsrapport juli-september 2025",
        "category": "Interimsrapport",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=b9623e7e118c752eb34a564057ac11d47&lang=sv&src=listed",
        "language": "sv",
        "report_type": "interim-report",
        "fiscal_year": 2025,
        "quarter": "q3",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q3-2025",
            "title": "Kvartalsrapport Q3 2025",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/a54474f94e81f22f8f79db9eea5345820",
            "date": "2025-11-26",
            "period": "2025-q3",
            "form_type": "interim-report",
            "report_key": "2025:q3",
            "filename": "Immunovia_Delarsrapport_Q3_2025.pdf",
            "text_chars": 56928,
            "sha256": "b271e34cd6d179a57b367446b5b96b4cc5b4112ae24b7946235b01bd68a801dd",
            "url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q3-2025",
            "absolute_url": "https://spela.port0.org/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q3-2025",
            "txt_url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q3-2025/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q3-2025/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q3-2025/part-001.html",
                "chars": 56928
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2025:q2",
        "period_label": "2025 Q2",
        "date": "2025-08-28",
        "title": "Kvartalsrapport Q2 2025",
        "original_title": "Immunovia publicerar Delårsrapport januari-juni 2025",
        "category": "Halvårsrapport",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=b8b0daac652727508919c33b0b9551583&lang=sv&src=listed",
        "language": "sv",
        "report_type": "interim-report",
        "fiscal_year": 2025,
        "quarter": "q2",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q2-2025",
            "title": "Kvartalsrapport Q2 2025",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/a34ac50a6b43e88fafab56acaa607b867",
            "date": "2025-08-28",
            "period": "2025-q2",
            "form_type": "interim-report",
            "report_key": "2025:q2",
            "filename": "Immunovia_Delarsrapport_Q2_2025.pdf",
            "text_chars": 52590,
            "sha256": "cdfeedad1fe434d611f256fabfc55b97bcec98532c0badfbc45ba8a722de0883",
            "url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q2-2025",
            "absolute_url": "https://spela.port0.org/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q2-2025",
            "txt_url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q2-2025/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q2-2025/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q2-2025/part-001.html",
                "chars": 52590
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2025:q1",
        "period_label": "2025 Q1",
        "date": "2025-05-14",
        "title": "Kvartalsrapport Q1 2025",
        "original_title": "Immunovia publicerar Delårsrapport januari-mars 2025",
        "category": "Interimsrapport",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=b41388f6bed50cdb8c4704cb71e9c73c6&lang=sv&src=listed",
        "language": "sv",
        "report_type": "interim-report",
        "fiscal_year": 2025,
        "quarter": "q1",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2025",
            "title": "Kvartalsrapport Q1 2025",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/a4c207209390b4129817aaef9aed0e724",
            "date": "2025-05-14",
            "period": "2025-q1",
            "form_type": "interim-report",
            "report_key": "2025:q1",
            "filename": "Immunovia_Delarsrapport_Q1_2025.pdf",
            "text_chars": 49052,
            "sha256": "0998c3898b3b41de80babf449ac83e5b37f5faa319bc1318556c743722283306",
            "url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q1-2025",
            "absolute_url": "https://spela.port0.org/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q1-2025",
            "txt_url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q1-2025/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q1-2025/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q1-2025/part-001.html",
                "chars": 49052
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2024:annual",
        "period_label": "2024 Årsredovisning",
        "date": "2025-04-02",
        "title": "Årsredovisning 2024",
        "original_title": "Immunovia publicerar årsredovisningen för 2024",
        "category": "Bokslut och Verksamhetsberättelse",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=bc44d41fa956d8be3c0465865957090ee&lang=sv&src=listed",
        "language": "sv",
        "report_type": "annual-report",
        "fiscal_year": 2024,
        "quarter": "annual",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-arsredovisning-2024",
            "title": "Årsredovisning 2024",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/ad8f82bcabe6b205567357ba5b348dd01",
            "date": "2025-04-02",
            "period": "2024-annual",
            "form_type": "annual-report",
            "report_key": "2024:annual",
            "filename": "04010960.pdf",
            "text_chars": 171458,
            "sha256": "a4515cc4b07797264935dbcff2789cfdf6bf2969bf78883aebc2bec5143746bd",
            "url": "/company/immunovia/documents/nasdaq-nordic-arsredovisning-2024",
            "absolute_url": "https://spela.port0.org/company/immunovia/documents/nasdaq-nordic-arsredovisning-2024",
            "txt_url": "/company/immunovia/documents/nasdaq-nordic-arsredovisning-2024/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/immunovia/documents/nasdaq-nordic-arsredovisning-2024/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/immunovia/documents/nasdaq-nordic-arsredovisning-2024/part-001.html",
                "chars": 171458
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2024:q4",
        "period_label": "2024 Q4",
        "date": "2025-02-25",
        "title": "Kvartalsrapport Q4 2024",
        "original_title": "Immunovia publicerar Bokslutskommuniké 2024",
        "category": "Bokslutskommuniké",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=b212d1c22005999027287c160918d11a0&lang=sv&src=listed",
        "language": "sv",
        "report_type": "year-end-report",
        "fiscal_year": 2024,
        "quarter": "q4",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q4-2024",
            "title": "Kvartalsrapport Q4 2024",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/abe1f005fa7d4e8f7d69c5443ceb81adf",
            "date": "2025-02-25",
            "period": "2024-q4",
            "form_type": "year-end-report",
            "report_key": "2024:q4",
            "filename": "02241926.pdf",
            "text_chars": 52992,
            "sha256": "05a51c33048ff12a3e5f66bd75db3a908aaa5cb10acc4deee349495cf05e0f99",
            "url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q4-2024",
            "absolute_url": "https://spela.port0.org/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q4-2024",
            "txt_url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q4-2024/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q4-2024/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q4-2024/part-001.html",
                "chars": 52992
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2024:q3",
        "period_label": "2024 Q3",
        "date": "2024-11-27",
        "title": "Kvartalsrapport Q3 2024",
        "original_title": "Immunovia publicerar Delårsrapport januari-september 2024",
        "category": "Interimsrapport",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=b8b53f31aecfb743c65abdf35b7833931&lang=sv&src=listed",
        "language": "sv",
        "report_type": "interim-report",
        "fiscal_year": 2024,
        "quarter": "q3",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q3-2024",
            "title": "Kvartalsrapport Q3 2024",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/acd18c866d911da5e4edb17009d06304a",
            "date": "2024-11-27",
            "period": "2024-q3",
            "form_type": "interim-report",
            "report_key": "2024:q3",
            "filename": "11263202.pdf",
            "text_chars": 52618,
            "sha256": "3a806c9f778c8ff2f04b94fd3a6cadfaaae0eedeae12f90fae764ae9eacf0266",
            "url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q3-2024",
            "absolute_url": "https://spela.port0.org/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q3-2024",
            "txt_url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q3-2024/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q3-2024/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q3-2024/part-001.html",
                "chars": 52618
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2024:q2",
        "period_label": "2024 Q2",
        "date": "2024-08-05",
        "title": "Kvartalsrapport Q2 2024",
        "original_title": "Immunovia publicerar Delårsrapport januari-juni 2024",
        "category": "Halvårsrapport",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=b25c580428d5814df1e00619cdca80c88&lang=sv&src=listed",
        "language": "sv",
        "report_type": "interim-report",
        "fiscal_year": 2024,
        "quarter": "q2",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q2-2024",
            "title": "Kvartalsrapport Q2 2024",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/af0c0fc60f1be8e297da6c1197aa1fd20",
            "date": "2024-08-05",
            "period": "2024-q2",
            "form_type": "interim-report",
            "report_key": "2024:q2",
            "filename": "08041669.pdf",
            "text_chars": 51580,
            "sha256": "df5a5c22c0fd818bab44b1bf857e17f3598c490f53539889486bf2758bb0e91a",
            "url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q2-2024",
            "absolute_url": "https://spela.port0.org/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q2-2024",
            "txt_url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q2-2024/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q2-2024/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q2-2024/part-001.html",
                "chars": 51580
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2024:q1",
        "period_label": "2024 Q1",
        "date": "2024-04-29",
        "title": "Kvartalsrapport Q1 2024",
        "original_title": "Immunovia publicerar Delårsrapport januari-mars 2024",
        "category": "Interimsrapport",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=b4d0abd112c5a082193b9e1be811299f4&lang=sv&src=listed",
        "language": "sv",
        "report_type": "interim-report",
        "fiscal_year": 2024,
        "quarter": "q1",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2024",
            "title": "Kvartalsrapport Q1 2024",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/a4e47857722f4af0dda08663c0e7fa1a0",
            "date": "2024-04-29",
            "period": "2024-q1",
            "form_type": "interim-report",
            "report_key": "2024:q1",
            "filename": "04289478.pdf",
            "text_chars": 47070,
            "sha256": "5d01116aeaa35137c5bc6e02fba92f7dc66eaaf2032bf2cd528e3d0173bc83f4",
            "url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q1-2024",
            "absolute_url": "https://spela.port0.org/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q1-2024",
            "txt_url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q1-2024/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q1-2024/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q1-2024/part-001.html",
                "chars": 47070
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2023:annual",
        "period_label": "2023 Årsredovisning",
        "date": "2024-04-29",
        "title": "Årsredovisning 2023",
        "original_title": "Immunovia publicerar årsredovisningen för 2023",
        "category": "Bokslut och Verksamhetsberättelse",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=bbd4042338269ccc77bd024770608b8d7&lang=sv&src=listed",
        "language": "sv",
        "report_type": "annual-report",
        "fiscal_year": 2023,
        "quarter": "annual",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-arsredovisning-2023",
            "title": "Årsredovisning 2023",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/a70dcaddefd57dbbd8b33a06aa4bc8ce2",
            "date": "2024-04-29",
            "period": "2023-annual",
            "form_type": "annual-report",
            "report_key": "2023:annual",
            "filename": "04299763.pdf",
            "text_chars": 190758,
            "sha256": "d777c5ae5528db58596f43a25d96705db22e4de68e60408f17d23268cefb6319",
            "url": "/company/immunovia/documents/nasdaq-nordic-arsredovisning-2023",
            "absolute_url": "https://spela.port0.org/company/immunovia/documents/nasdaq-nordic-arsredovisning-2023",
            "txt_url": "/company/immunovia/documents/nasdaq-nordic-arsredovisning-2023/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/immunovia/documents/nasdaq-nordic-arsredovisning-2023/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/immunovia/documents/nasdaq-nordic-arsredovisning-2023/part-001.html",
                "chars": 178828
              },
              {
                "number": 2,
                "url": "/company/immunovia/documents/nasdaq-nordic-arsredovisning-2023/part-002.html",
                "chars": 11928
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2023:q4",
        "period_label": "2023 Q4",
        "date": "2024-02-21",
        "title": "Kvartalsrapport Q4 2023",
        "original_title": "Immunovia publicerar Bokslutskommuniké 2023",
        "category": "Bokslutskommuniké",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=b91785184b96209906ea0184ec9195341&lang=sv&src=listed",
        "language": "sv",
        "report_type": "year-end-report",
        "fiscal_year": 2023,
        "quarter": "q4",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q4-2023",
            "title": "Kvartalsrapport Q4 2023",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/a6a47d32a9fd60e7b8bd200d032a951f0",
            "date": "2024-02-21",
            "period": "2023-q4",
            "form_type": "year-end-report",
            "report_key": "2023:q4",
            "filename": "02202332.pdf",
            "text_chars": 57447,
            "sha256": "20dcbea82e241e3a7bedc430d19d1720115f11eee5508a11099b01cb5c79b86f",
            "url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q4-2023",
            "absolute_url": "https://spela.port0.org/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q4-2023",
            "txt_url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q4-2023/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q4-2023/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q4-2023/part-001.html",
                "chars": 57447
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2023:q3",
        "period_label": "2023 Q3",
        "date": "2023-11-09",
        "title": "Kvartalsrapport Q3 2023",
        "original_title": "Immunovia publicerar Delårsrapport januari-september 2023",
        "category": "Interimsrapport",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=bdaf84d6ee2ea08b443bd4c0baa498b72&lang=sv&src=listed",
        "language": "sv",
        "report_type": "interim-report",
        "fiscal_year": 2023,
        "quarter": "q3",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q3-2023",
            "title": "Kvartalsrapport Q3 2023",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/aec57324595315300aeeaee2a72ce03c8",
            "date": "2023-11-09",
            "period": "2023-q3",
            "form_type": "interim-report",
            "report_key": "2023:q3",
            "filename": "11081246.pdf",
            "text_chars": 56339,
            "sha256": "5081fce965b0350cac4df4eaad2f897e4684914745bee61c519ec6e2a962c46d",
            "url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q3-2023",
            "absolute_url": "https://spela.port0.org/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q3-2023",
            "txt_url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q3-2023/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q3-2023/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q3-2023/part-001.html",
                "chars": 56339
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2023:q2",
        "period_label": "2023 Q2",
        "date": "2023-08-30",
        "title": "Kvartalsrapport Q2 2023",
        "original_title": "Immunovia publicerar Delårsrapport januari-juni 2023",
        "category": "Halvårsrapport",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=b371e6323aef2194d84e4c7ecc2d89e30&lang=sv&src=listed",
        "language": "sv",
        "report_type": "interim-report",
        "fiscal_year": 2023,
        "quarter": "q2",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q2-2023",
            "title": "Kvartalsrapport Q2 2023",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/aef1296542205e39180d2c63a5aa2de4b",
            "date": "2023-08-30",
            "period": "2023-q2",
            "form_type": "interim-report",
            "report_key": "2023:q2",
            "filename": "08294671.pdf",
            "text_chars": 55030,
            "sha256": "d3df7868ec951e4987f7a56ad78374700ecc020c9947dc06d022301d0b5ac249",
            "url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q2-2023",
            "absolute_url": "https://spela.port0.org/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q2-2023",
            "txt_url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q2-2023/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q2-2023/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q2-2023/part-001.html",
                "chars": 55030
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2023:q1",
        "period_label": "2023 Q1",
        "date": "2023-05-23",
        "title": "Kvartalsrapport Q1 2023",
        "original_title": "Immunovia publicerar Delårsrapport januari-mars 2023",
        "category": "Interimsrapport",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=b81a20371a4ce5834b89f9ae6b27303b4&lang=sv&src=listed",
        "language": "sv",
        "report_type": "interim-report",
        "fiscal_year": 2023,
        "quarter": "q1",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2023",
            "title": "Kvartalsrapport Q1 2023",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/a624425c262bab7d0258e72e8ab48e1f2",
            "date": "2023-05-23",
            "period": "2023-q1",
            "form_type": "interim-report",
            "report_key": "2023:q1",
            "filename": "05220986.pdf",
            "text_chars": 50387,
            "sha256": "dcf8f047fbd1ff2984ea9e64777cc635cc14a2016082b71926900a213fd51942",
            "url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q1-2023",
            "absolute_url": "https://spela.port0.org/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q1-2023",
            "txt_url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q1-2023/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q1-2023/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q1-2023/part-001.html",
                "chars": 50387
              }
            ]
          }
        ],
        "alternatives": []
      }
    ]
  },
  "report_count": 17,
  "nasdaq_report_count": 17,
  "mfn_fallback_count": 0,
  "sec_status": "skipped",
  "sec_count": 0,
  "fi_status": "retrieved",
  "fi_summary": {
    "company": "Immunovia",
    "identity": {
      "issuer": "Immunovia AB (publ)",
      "lei": "549300KHWL6KK1XGUO81",
      "source": "FI aggregerade blankningspositioner",
      "row_count": 10,
      "score": 118.0,
      "status": "resolved",
      "requested_company": "Immunovia",
      "query": "Immunovia AB (publ)",
      "candidate_count": 345
    },
    "period": {
      "from": "2024-08-07",
      "to": "2026-08-07",
      "years": 2
    },
    "generated_at": "2026-08-07T04:13:08Z",
    "insider": {
      "transactions": 9,
      "all_export_rows": 9,
      "acquisitions": 1,
      "disposals": 0,
      "other": 8,
      "acquisition_value_sek": 41650.8,
      "disposal_value_sek": 0,
      "characters": {
        "Förvärv": 1,
        "Lösen minskning": 2,
        "Teckning": 5,
        "Tilldelning": 1
      }
    },
    "short_selling": {
      "aggregate_percent": 1.04,
      "current_public_positions": 1,
      "historical_changes": 47,
      "current_position_sum_over_0_5": 0.69
    },
    "sources": {
      "insider_register": "https://www.fi.se/sv/vara-register/insynsregistret/",
      "short_register": "https://www.fi.se/sv/vara-register/blankningsregistret/"
    }
  },
  "warnings": [
    "MFN fallback: resolved_no_reports"
  ],
  "source_identity": {
    "nasdaq_reports": {
      "slug": "",
      "instrument_id": "TX1932150",
      "resolved_url": "https://www.nasdaq.com/european-market-activity/shares/immnov?id=TX1932150"
    },
    "mfn": {
      "status": "resolved",
      "company_name": "Immunovia",
      "expected_name": "Immunovia",
      "match_score": 100.0,
      "slug": "immunovia",
      "url": "https://mfn.se/all/a/immunovia",
      "metadata": {
        "country": "Sverige",
        "list": "Small Cap Stockholm",
        "sector": "Hälsovård",
        "industry": "Bioteknik",
        "website": "https://career.modularfinance.se"
      },
      "ticker_candidates": [],
      "attempts": []
    },
    "sec": null,
    "nasdaq": {
      "instrument_id": "TX1932150",
      "asset_class": "SHARES",
      "isin": "SE0006091997",
      "symbol": "IMMNOV",
      "company": "Immunovia",
      "market": null,
      "last_sale_price": "SEK 0.1756",
      "time_as_of": "2026-08-06"
    },
    "finansinspektionen": {
      "issuer": "Immunovia AB (publ)",
      "lei": "549300KHWL6KK1XGUO81",
      "source": "FI aggregerade blankningspositioner",
      "row_count": 10,
      "score": 118.0,
      "status": "resolved",
      "requested_company": "Immunovia",
      "query": "Immunovia AB (publ)",
      "candidate_count": 345
    }
  },
  "documents": [
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q2-2026",
      "title": "Kvartalsrapport Q2 2026",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/ae1f417bd344855d4ceb5689dc8cbb99a",
      "date": "2026-08-06",
      "period": "2026-q2",
      "form_type": "interim-report",
      "report_key": "2026:q2",
      "filename": "Immunovia_Delarsrapport_Q2_2026.pdf",
      "text_chars": 54040,
      "sha256": "dd64257dad51d8e061ea554c48d6f4705c367b942e47569c3f24b02b0c4de2dc",
      "url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q2-2026",
      "absolute_url": "https://spela.port0.org/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q2-2026",
      "txt_url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q2-2026/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q2-2026/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q2-2026/part-001.html",
          "chars": 54040
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2026",
      "title": "Kvartalsrapport Q1 2026",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/a9f26903c3283771aae8384f7671d2965",
      "date": "2026-05-07",
      "period": "2026-q1",
      "form_type": "interim-report",
      "report_key": "2026:q1",
      "filename": "Immunovia_Delarsrapport_Q1_2026.pdf",
      "text_chars": 51299,
      "sha256": "82e9edf4b17f2d80be0d79e78b699609f88a57293279f46a189ff73ed86cb4b4",
      "url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q1-2026",
      "absolute_url": "https://spela.port0.org/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q1-2026",
      "txt_url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q1-2026/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q1-2026/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q1-2026/part-001.html",
          "chars": 51299
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-arsredovisning-2025",
      "title": "Årsredovisning 2025",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/a003a0716b3c489d57e20b93cb41e4694",
      "date": "2026-04-10",
      "period": "2025-annual",
      "form_type": "annual-report",
      "report_key": "2025:annual",
      "filename": "Immunovia_AB_publ_Arsredovisning_2025.pdf",
      "text_chars": 180734,
      "sha256": "5835d188655b3c9f74e66c3ca06c35c44edf4fe2635245fa7978fbb34fd49ac5",
      "url": "/company/immunovia/documents/nasdaq-nordic-arsredovisning-2025",
      "absolute_url": "https://spela.port0.org/company/immunovia/documents/nasdaq-nordic-arsredovisning-2025",
      "txt_url": "/company/immunovia/documents/nasdaq-nordic-arsredovisning-2025/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/immunovia/documents/nasdaq-nordic-arsredovisning-2025/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/immunovia/documents/nasdaq-nordic-arsredovisning-2025/part-001.html",
          "chars": 179700
        },
        {
          "number": 2,
          "url": "/company/immunovia/documents/nasdaq-nordic-arsredovisning-2025/part-002.html",
          "chars": 1032
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q4-2025",
      "title": "Kvartalsrapport Q4 2025",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/a9a34f3722386ab8c29d882a04d530924",
      "date": "2026-02-24",
      "period": "2025-q4",
      "form_type": "year-end-report",
      "report_key": "2025:q4",
      "filename": "Bokslutskommunike_2025.pdf",
      "text_chars": 52683,
      "sha256": "2c0698add5bcd649088d1f7d8281bcf564f857711ae658b11c6ef51fe29ac391",
      "url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q4-2025",
      "absolute_url": "https://spela.port0.org/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q4-2025",
      "txt_url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q4-2025/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q4-2025/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q4-2025/part-001.html",
          "chars": 52683
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q3-2025",
      "title": "Kvartalsrapport Q3 2025",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/a54474f94e81f22f8f79db9eea5345820",
      "date": "2025-11-26",
      "period": "2025-q3",
      "form_type": "interim-report",
      "report_key": "2025:q3",
      "filename": "Immunovia_Delarsrapport_Q3_2025.pdf",
      "text_chars": 56928,
      "sha256": "b271e34cd6d179a57b367446b5b96b4cc5b4112ae24b7946235b01bd68a801dd",
      "url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q3-2025",
      "absolute_url": "https://spela.port0.org/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q3-2025",
      "txt_url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q3-2025/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q3-2025/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q3-2025/part-001.html",
          "chars": 56928
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q2-2025",
      "title": "Kvartalsrapport Q2 2025",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/a34ac50a6b43e88fafab56acaa607b867",
      "date": "2025-08-28",
      "period": "2025-q2",
      "form_type": "interim-report",
      "report_key": "2025:q2",
      "filename": "Immunovia_Delarsrapport_Q2_2025.pdf",
      "text_chars": 52590,
      "sha256": "cdfeedad1fe434d611f256fabfc55b97bcec98532c0badfbc45ba8a722de0883",
      "url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q2-2025",
      "absolute_url": "https://spela.port0.org/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q2-2025",
      "txt_url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q2-2025/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q2-2025/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q2-2025/part-001.html",
          "chars": 52590
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2025",
      "title": "Kvartalsrapport Q1 2025",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/a4c207209390b4129817aaef9aed0e724",
      "date": "2025-05-14",
      "period": "2025-q1",
      "form_type": "interim-report",
      "report_key": "2025:q1",
      "filename": "Immunovia_Delarsrapport_Q1_2025.pdf",
      "text_chars": 49052,
      "sha256": "0998c3898b3b41de80babf449ac83e5b37f5faa319bc1318556c743722283306",
      "url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q1-2025",
      "absolute_url": "https://spela.port0.org/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q1-2025",
      "txt_url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q1-2025/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q1-2025/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q1-2025/part-001.html",
          "chars": 49052
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-arsredovisning-2024",
      "title": "Årsredovisning 2024",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/ad8f82bcabe6b205567357ba5b348dd01",
      "date": "2025-04-02",
      "period": "2024-annual",
      "form_type": "annual-report",
      "report_key": "2024:annual",
      "filename": "04010960.pdf",
      "text_chars": 171458,
      "sha256": "a4515cc4b07797264935dbcff2789cfdf6bf2969bf78883aebc2bec5143746bd",
      "url": "/company/immunovia/documents/nasdaq-nordic-arsredovisning-2024",
      "absolute_url": "https://spela.port0.org/company/immunovia/documents/nasdaq-nordic-arsredovisning-2024",
      "txt_url": "/company/immunovia/documents/nasdaq-nordic-arsredovisning-2024/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/immunovia/documents/nasdaq-nordic-arsredovisning-2024/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/immunovia/documents/nasdaq-nordic-arsredovisning-2024/part-001.html",
          "chars": 171458
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q4-2024",
      "title": "Kvartalsrapport Q4 2024",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/abe1f005fa7d4e8f7d69c5443ceb81adf",
      "date": "2025-02-25",
      "period": "2024-q4",
      "form_type": "year-end-report",
      "report_key": "2024:q4",
      "filename": "02241926.pdf",
      "text_chars": 52992,
      "sha256": "05a51c33048ff12a3e5f66bd75db3a908aaa5cb10acc4deee349495cf05e0f99",
      "url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q4-2024",
      "absolute_url": "https://spela.port0.org/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q4-2024",
      "txt_url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q4-2024/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q4-2024/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q4-2024/part-001.html",
          "chars": 52992
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q3-2024",
      "title": "Kvartalsrapport Q3 2024",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/acd18c866d911da5e4edb17009d06304a",
      "date": "2024-11-27",
      "period": "2024-q3",
      "form_type": "interim-report",
      "report_key": "2024:q3",
      "filename": "11263202.pdf",
      "text_chars": 52618,
      "sha256": "3a806c9f778c8ff2f04b94fd3a6cadfaaae0eedeae12f90fae764ae9eacf0266",
      "url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q3-2024",
      "absolute_url": "https://spela.port0.org/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q3-2024",
      "txt_url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q3-2024/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q3-2024/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q3-2024/part-001.html",
          "chars": 52618
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q2-2024",
      "title": "Kvartalsrapport Q2 2024",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/af0c0fc60f1be8e297da6c1197aa1fd20",
      "date": "2024-08-05",
      "period": "2024-q2",
      "form_type": "interim-report",
      "report_key": "2024:q2",
      "filename": "08041669.pdf",
      "text_chars": 51580,
      "sha256": "df5a5c22c0fd818bab44b1bf857e17f3598c490f53539889486bf2758bb0e91a",
      "url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q2-2024",
      "absolute_url": "https://spela.port0.org/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q2-2024",
      "txt_url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q2-2024/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q2-2024/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q2-2024/part-001.html",
          "chars": 51580
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-arsredovisning-2023",
      "title": "Årsredovisning 2023",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/a70dcaddefd57dbbd8b33a06aa4bc8ce2",
      "date": "2024-04-29",
      "period": "2023-annual",
      "form_type": "annual-report",
      "report_key": "2023:annual",
      "filename": "04299763.pdf",
      "text_chars": 190758,
      "sha256": "d777c5ae5528db58596f43a25d96705db22e4de68e60408f17d23268cefb6319",
      "url": "/company/immunovia/documents/nasdaq-nordic-arsredovisning-2023",
      "absolute_url": "https://spela.port0.org/company/immunovia/documents/nasdaq-nordic-arsredovisning-2023",
      "txt_url": "/company/immunovia/documents/nasdaq-nordic-arsredovisning-2023/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/immunovia/documents/nasdaq-nordic-arsredovisning-2023/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/immunovia/documents/nasdaq-nordic-arsredovisning-2023/part-001.html",
          "chars": 178828
        },
        {
          "number": 2,
          "url": "/company/immunovia/documents/nasdaq-nordic-arsredovisning-2023/part-002.html",
          "chars": 11928
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2024",
      "title": "Kvartalsrapport Q1 2024",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/a4e47857722f4af0dda08663c0e7fa1a0",
      "date": "2024-04-29",
      "period": "2024-q1",
      "form_type": "interim-report",
      "report_key": "2024:q1",
      "filename": "04289478.pdf",
      "text_chars": 47070,
      "sha256": "5d01116aeaa35137c5bc6e02fba92f7dc66eaaf2032bf2cd528e3d0173bc83f4",
      "url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q1-2024",
      "absolute_url": "https://spela.port0.org/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q1-2024",
      "txt_url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q1-2024/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q1-2024/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q1-2024/part-001.html",
          "chars": 47070
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q4-2023",
      "title": "Kvartalsrapport Q4 2023",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/a6a47d32a9fd60e7b8bd200d032a951f0",
      "date": "2024-02-21",
      "period": "2023-q4",
      "form_type": "year-end-report",
      "report_key": "2023:q4",
      "filename": "02202332.pdf",
      "text_chars": 57447,
      "sha256": "20dcbea82e241e3a7bedc430d19d1720115f11eee5508a11099b01cb5c79b86f",
      "url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q4-2023",
      "absolute_url": "https://spela.port0.org/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q4-2023",
      "txt_url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q4-2023/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q4-2023/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q4-2023/part-001.html",
          "chars": 57447
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q3-2023",
      "title": "Kvartalsrapport Q3 2023",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/aec57324595315300aeeaee2a72ce03c8",
      "date": "2023-11-09",
      "period": "2023-q3",
      "form_type": "interim-report",
      "report_key": "2023:q3",
      "filename": "11081246.pdf",
      "text_chars": 56339,
      "sha256": "5081fce965b0350cac4df4eaad2f897e4684914745bee61c519ec6e2a962c46d",
      "url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q3-2023",
      "absolute_url": "https://spela.port0.org/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q3-2023",
      "txt_url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q3-2023/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q3-2023/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q3-2023/part-001.html",
          "chars": 56339
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q2-2023",
      "title": "Kvartalsrapport Q2 2023",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/aef1296542205e39180d2c63a5aa2de4b",
      "date": "2023-08-30",
      "period": "2023-q2",
      "form_type": "interim-report",
      "report_key": "2023:q2",
      "filename": "08294671.pdf",
      "text_chars": 55030,
      "sha256": "d3df7868ec951e4987f7a56ad78374700ecc020c9947dc06d022301d0b5ac249",
      "url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q2-2023",
      "absolute_url": "https://spela.port0.org/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q2-2023",
      "txt_url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q2-2023/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q2-2023/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q2-2023/part-001.html",
          "chars": 55030
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2023",
      "title": "Kvartalsrapport Q1 2023",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/a624425c262bab7d0258e72e8ab48e1f2",
      "date": "2023-05-23",
      "period": "2023-q1",
      "form_type": "interim-report",
      "report_key": "2023:q1",
      "filename": "05220986.pdf",
      "text_chars": 50387,
      "sha256": "dcf8f047fbd1ff2984ea9e64777cc635cc14a2016082b71926900a213fd51942",
      "url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q1-2023",
      "absolute_url": "https://spela.port0.org/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q1-2023",
      "txt_url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q1-2023/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q1-2023/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/immunovia/documents/nasdaq-nordic-kvartalsrapport-q1-2023/part-001.html",
          "chars": 50387
        }
      ]
    },
    {
      "doc_id": "mfn-mfn-bolagssida-och-bolagsmetadata",
      "title": "MFN bolagssida och bolagsmetadata",
      "source": "MFN",
      "source_class": "mfn",
      "source_url": "https://mfn.se/all/a/immunovia",
      "date": null,
      "period": null,
      "form_type": "company-page",
      "report_key": null,
      "filename": "company.txt",
      "text_chars": 12747,
      "sha256": "67e0bf9104a6b557da1224ace8b76651511ee1dbc424757b27b7911e0bcb4e57",
      "url": "/company/immunovia/documents/mfn-mfn-bolagssida-och-bolagsmetadata",
      "absolute_url": "https://spela.port0.org/company/immunovia/documents/mfn-mfn-bolagssida-och-bolagsmetadata",
      "txt_url": "/company/immunovia/documents/mfn-mfn-bolagssida-och-bolagsmetadata/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/immunovia/documents/mfn-mfn-bolagssida-och-bolagsmetadata/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/immunovia/documents/mfn-mfn-bolagssida-och-bolagsmetadata/part-001.html",
          "chars": 12747
        }
      ]
    }
  ],
  "market_files": [
    {
      "label": "Nasdaq kurshistorik CSV",
      "url": "/company/immunovia/market/history.csv",
      "absolute_url": "https://spela.port0.org/company/immunovia/market/history.csv"
    },
    {
      "label": "Nasdaq kurshistorik JSON",
      "url": "/company/immunovia/market/history.json",
      "absolute_url": "https://spela.port0.org/company/immunovia/market/history.json"
    },
    {
      "label": "Nasdaq manifest JSON",
      "url": "/company/immunovia/market/manifest.json",
      "absolute_url": "https://spela.port0.org/company/immunovia/market/manifest.json"
    },
    {
      "label": "Nasdaq instrumentidentitet JSON",
      "url": "/company/immunovia/market/instrument.json",
      "absolute_url": "https://spela.port0.org/company/immunovia/market/instrument.json"
    },
    {
      "label": "MFN manifest JSON",
      "url": "/company/immunovia/market/mfn-manifest.json",
      "absolute_url": "https://spela.port0.org/company/immunovia/market/mfn-manifest.json"
    },
    {
      "label": "Nasdaq rapportmanifest JSON",
      "url": "/company/immunovia/market/nasdaq-reports-manifest.json",
      "absolute_url": "https://spela.port0.org/company/immunovia/market/nasdaq-reports-manifest.json"
    }
  ],
  "sec_facts": {
    "status": "missing",
    "metrics": []
  },
  "morningstar": {
    "configured": false,
    "status": "inte hämtad",
    "captured_at": null,
    "view_count": 0,
    "url": "/company/immunovia/morningstar"
  },
  "finansinspektionen": {
    "available": true,
    "status": "retrieved",
    "url": "/company/immunovia/finansinspektionen",
    "transaction_count": 9,
    "aggregate_short_percent": 1.04,
    "files": [
      {
        "filename": "summary.json",
        "label": "Sammanfattning JSON",
        "url": "summary.json"
      },
      {
        "filename": "insider-transactions.csv",
        "label": "Insynstransaktioner CSV",
        "url": "insider-transactions.csv"
      },
      {
        "filename": "insider-transactions.json",
        "label": "Insynstransaktioner JSON",
        "url": "insider-transactions.json"
      },
      {
        "filename": "short-current.json",
        "label": "Aktuella blankningspositioner JSON",
        "url": "short-current.json"
      },
      {
        "filename": "short-history.json",
        "label": "Historiska blankningspositioner JSON",
        "url": "short-history.json"
      },
      {
        "filename": "short-aggregate.json",
        "label": "Aggregerad blankning JSON",
        "url": "short-aggregate.json"
      },
      {
        "filename": "manifest.json",
        "label": "Hämtningsmanifest JSON",
        "url": "manifest.json"
      }
    ]
  },
  "llms_url": "/company/immunovia/llms.txt",
  "json_url": "/company/immunovia/company.json",
  "document_index_url": "/company/immunovia/documents.json",
  "absolute_url": "https://spela.port0.org/company/immunovia"
}